These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1501574)

  • 1. Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions.
    Rubin DH; Weiner DB; Dworkin C; Greene MI; Maul GG; Williams WV
    Microb Pathog; 1992 May; 12(5):351-65. PubMed ID: 1501574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1.
    Chappell JD; Gunn VL; Wetzel JD; Baer GS; Dermody TS
    J Virol; 1997 Mar; 71(3):1834-41. PubMed ID: 9032313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.
    Rubin DH; Wetzel JD; Williams WV; Cohen JA; Dworkin C; Dermody TS
    J Clin Invest; 1992 Dec; 90(6):2536-42. PubMed ID: 1281838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the beta-adrenergic receptor function as a reovirus receptor?
    Choi AH; Lee PW
    Virology; 1988 Mar; 163(1):191-7. PubMed ID: 2831655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotypic antibody identifies the cellular receptor of reovirus type 3.
    Gaulton G; Co MS; Greene MI
    J Cell Biochem; 1985; 28(1):69-78. PubMed ID: 3875619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells.
    Gentsch JR; Pacitti AF
    J Virol; 1985 Nov; 56(2):356-64. PubMed ID: 4057353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.
    Co MS; Gaulton GN; Tominaga A; Homcy CJ; Fields BN; Greene MI
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5315-8. PubMed ID: 2991918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.
    Frierson JM; Pruijssers AJ; Konopka JL; Reiter DM; Abel TW; Stehle T; Dermody TS
    J Virol; 2012 Dec; 86(24):13164-73. PubMed ID: 23035227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of reovirus type 3 binding to host cells by sialylated glycoproteins is mediated through the viral attachment protein.
    Pacitti AF; Gentsch JR
    J Virol; 1987 May; 61(5):1407-15. PubMed ID: 3573143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of 125I-labeled reovirus to cell surface receptors.
    Epstein RL; Powers ML; Rogart RB; Weiner HL
    Virology; 1984 Feb; 133(1):46-55. PubMed ID: 6702106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein.
    Nibert ML; Chappell JD; Dermody TS
    J Virol; 1995 Aug; 69(8):5057-67. PubMed ID: 7609075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses.
    Chappell JD; Duong JL; Wright BW; Dermody TS
    J Virol; 2000 Sep; 74(18):8472-9. PubMed ID: 10954547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.
    Mohamed A; Teicher C; Haefliger S; Shmulevitz M
    J Virol; 2015 Apr; 89(8):4319-34. PubMed ID: 25653434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell receptors for the mammalian reovirus. II. Monoclonal anti-idiotypic antibody blocks viral binding to cells.
    Kauffman RS; Noseworthy JH; Nepom JT; Finberg R; Fields BN; Greene MI
    J Immunol; 1983 Nov; 131(5):2539-41. PubMed ID: 6313806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.
    van den Wollenberg DJ; Dautzenberg IJ; van den Hengel SK; Cramer SJ; de Groot RJ; Hoeben RC
    PLoS One; 2012; 7(10):e48064. PubMed ID: 23110175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of exogenous protease facilitates reovirus infection in many restrictive cells.
    Golden JW; Linke J; Schmechel S; Thoemke K; Schiff LA
    J Virol; 2002 Aug; 76(15):7430-43. PubMed ID: 12097555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta1 integrin mediates internalization of mammalian reovirus.
    Maginnis MS; Forrest JC; Kopecky-Bromberg SA; Dickeson SK; Santoro SA; Zutter MM; Nemerow GR; Bergelson JM; Dermody TS
    J Virol; 2006 Mar; 80(6):2760-70. PubMed ID: 16501085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific plasma membrane receptors for reovirus on rat pituitary cells in culture.
    Maratos-Flier E; Kahn CR; Spriggs DR; Fields BN
    J Clin Invest; 1983 Aug; 72(2):617-21. PubMed ID: 6308058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.
    Baer GS; Ebert DH; Chung CJ; Erickson AH; Dermody TS
    J Virol; 1999 Nov; 73(11):9532-43. PubMed ID: 10516062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.